Catalytic nanomedicine technology: Copper complexes loaded on titania nanomaterials as cytotoxic agents of cancer cell

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 581-592

  Lopez, Tessy ^a,b,c   Ortiz Islas, Emma ^b   Guevara, Patricia ^b   Gómez, Esteban ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c Tulane University   (United States)

Author keywords

Anticancer properties; Cancer cell lines; Functionalized TiO2; Toxic effect

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLACETONATE COPPER; CISPLATIN; COPPER ACETATE; COPPER COMPLEX; NANOMATERIAL; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

ADSORPTION; ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CELL ASSAY; CELL SPECIFICITY; CELL STRAIN B16; CELL STRAIN C6; CELL STRAIN RG2; CELL STRAIN U373; CELL VIABILITY; CHEMICAL PROCEDURES; CONCENTRATION RESPONSE; DESORPTION; DRUG CYTOTOXICITY; DRUG RELEASE; FIRST ORDER KINETICS; IN VITRO STUDY; KINETICS; NANOTECHNOLOGY; PHYSICAL CHEMISTRY; ROOM TEMPERATURE; SOL GEL PROCESS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; ZERO ORDER KINETICS;

ANTICANCER PROPERTIES; CANCER CELL LINES; FUNCTIONALIZED-TIO; TOXIC EFFECT;

ADSORPTION; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; COORDINATION COMPLEXES; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOMEDICINE; NANOPARTICLES; PARTICLE SIZE; RATS; TITANIUM;

EID: 84873690941     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37118     Document Type: Article

References (37)

1. Siegel R, Ward E, Brawley O, Jemal A. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Ca Cancer J Clin. 2011;61(4):212-236.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin. 2011;61(2):69-90.
3. Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011; 165(7-8):1628-1651.
4. Wang X, Wang Y, Chen ZG, Shin DM. Advances of cancer therapy by nanotechnology. Cancer Res Treat. 2009;41(1):1-11.
5. Rosenberg B, VanCamp L, Trosko JE, Mansour VH. Platinum compounds: a new class of potent antitumour agents. Nature. 1969; 222(5191):385-386.
6. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573-584.
7. Bogdanović G, Kojić V, Srdić T, et al. Growth effects of some platinum(II) complexes with sulfur-containing carrier ligands on MCF7 human breast cancer cell line upon simultaneous administration with Taxol. Met Based Drugs. 2002;9(1-2):33-43.
8. Kendall J, Liu Q, Bakleh A, et al. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer. Proc Natl Acad Sci U S A. 2007;104(42):16663-16668.
9. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2(11):2490-2518.
10. Faubel S, Lewis EC, Reznikov L, et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther. 2007;322(1):8-15.
11. Tardito S, Marchiò L. Copper compounds in anticancer strategies. Curr Med Chem. 2009;16(11):1325-1348.
12. Iakovidis I, Delimaris I, Piperakis SM. Copper and its complexes in medicine: a biochemical approach. Mol Biol Int. Epub June 15, 2011.
13. Hancock CN, Stockwin LH, Han B, et al. A copper chelate of thio-semicarbazone NSC 689534induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo. Free Radic Biol Med. 2011;50(1): 110-121.
14. Rajalakshmi S, Weyhermüller T, Freddy AJ, Vasanthi HR, Nair BU. Anomalous behavior of pentacoordinate copper complexes of dimethylphenanthroline and derivatives of terpyridine ligands: studies on DNA binding, cleavage and apoptotic activity. Eur J Med Chem. 2011;46(2):608-617.
15. Santini C, Pellei M, Papini G, et al. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands. J Inorg Biochem. 2011;105(2):232-240.
16. Patitungkho S, Adsule S, Dandawate P, Padhye S, Ahmad A, Sarkar FH. Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines. Bioorg Med Chem Lett. 2011;21(6):1802-1806.
17. Patra AK, Bhowmick T, Roy S, Ramakumar S, Chakravarty AR. Copper(II) complexes of L-arginine as netropsin mimics showing DNA cleavage activity in red light. Inorg Chem. 2009;48(7):2932-2943.
18. Tseng TS, Burstyn JN. Synthesis and DNA cleavage activity of a bifunctional intercalator-linked copper (II) macrocycle. Chem Commun (Camb). 2008;(46):6209-6211.
19. Tardito S, Bassanetti I, Bignardi C, et al. Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells. J Am Chem Soc. 2011;133(16):6235-6242.
20. López T, Recillas S, Guevara P, Sotelo J, Alvarez M, Odriozola JA. Acta Biomater. 2008;4(6):2037-2044.
21. López T, Figueras F, Manjarrez J, et al. Catalytic nanomedicine: a new field in antitumor treatment using supported platinum nanoparticles. In vitro DNA degradation and in vivo tests with C6 animal model on Wistar rats. Eur J Med Chem. 2010;45(5):1982-1990.
22. López T, Ortiz-Islas E, Guevara P, Rios JV. Preparation and characterization of copper compounds co-gelled with nanostructured TiO2 materials to be used in cancer treatment. Sci Adv Mater. 2012;4:579-583.
23. Wang ZL. Characterization of nanophase materials. In: Wang ZL, editor. Transmission Electron Microscopy and Spectroscopy of Nanoparticles. Weinheim: Wiley-VCH Verlag GmbH; 2000:37-41.
24. Leonard K. TEM and Electron Diffraction, College of Engineering and Applied Science, U Cincinnati; 1999. Available from: http://www.eng.uc.edu/~gbeaucag/Classes/XRD/Labs/Keithhtml/Keith.pdf. Accessed. August 12, 2012.
25. López T, Alvarez M, González RD, et al. Synthesis, characterization and in vitro cytotoxicity of Pt-TiO2 nanoparticles. Adsorption. 2011;17: 573-581.
26. Bokhimi X, Morales A, Novaro O, et al. Effect of copper precursor on the stabilization of titania phases, and the optical properties of Cu/TiO2 prepared with the sol-gel technique. Chem Mater. 1997;9:2616-2620.
27. Williams DB, Carter CB. Transmission Electron Microscopy. A Textbook for Materials Science. New York: Plenum Press; 1996.
28. Brunauer S, Deming LS, Edwards Deming W, Teller E. On a theory of the van der Waals adsorption of gases. J Am Chem Soc. 1940;62(7):1723-1732.
29. López T, Ortiz E, Alexander-Katz R, Basaldella E, Bokhimi X. Cortisol controlled release by mesoporous silica. Nanomedicine. 2009;5(2): 170-177.
30. López T, Ortiz E, Meza D, et al. Controlled release of phenytoin for epilepsy treatment from titania and silica based materials. Mat Chem Phy. 2011;126:922-929.
31. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110-111.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
33. López T, Ortiz E, Alvarez M, et al. Catalytic nanomedicine: Functionalisation of nanostructured cryptomelane. Mat Chem Phy. 2010;120:518-525.
34. Papaliagkas V, Anogianaki A, Anogianakis G, Ilonidis G. The proteins and the mechanisms of apoptosis: A mini-review of the fundamentals. Hippokratia. 2007;11(3):108-113.
35. Muñoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012;3:e248.
36. Barve A, Kumbhar A, Bhat M, et al. Mixed-ligand copper(II) maltolate complexes: synthesis, characterization, DNA binding and cleavage, and cytotoxicity. Inorg Chem. 2009;48(19):9120-9132.
37. Mookerjee A, Basu JM, Majumder S, et al. A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo. BMC Cancer. 2006;6:267.